- Home
- DGII vs MNKD Comparison
DGII vs MNKD Comparison
Compare DGII & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DGII | MNKD |
|---|---|---|
| Founded | 1985 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | DGII | MNKD |
|---|---|---|
| Price | $43.58 | $6.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $46.80 | $10.08 |
| AVG Volume (30 Days) | 291.3K | ★ 2.8M |
| Earning Date | 02-04-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.05 | 23.47 |
| EPS | ★ 1.08 | 0.10 |
| Revenue | ★ $430,221,000.00 | $313,787,000.00 |
| Revenue This Year | $10.51 | $21.54 |
| Revenue Next Year | $8.01 | $22.21 |
| P/E Ratio | ★ $40.69 | $60.37 |
| Revenue Growth | 1.46 | ★ 17.43 |
| 52 Week Low | $22.39 | $3.38 |
| 52 Week High | $48.00 | $7.07 |
Technical Indicators
Market Signals| Indicator | DGII | MNKD |
|---|---|---|
| Relative Strength Index (RSI) | 55.71 | 66.16 |
| Support Level | $40.64 | $5.59 |
| Resistance Level | $48.00 | $6.01 |
| Average True Range (ATR) | 1.44 | 0.20 |
| MACD | -0.17 | 0.05 |
| Stochastic Oscillator | 39.95 | 86.31 |
Price Performance
Historical ComparisonAbout DGII Digi International Inc.
Digi International Inc is a Minnesota corporation. The company provides business and mission-critical and Internet of Things (IoT) connectivity products and services. It has two segments: IoT Products and Services and IoT Solutions. The IoT Products and Services segment consists of distinct communications products and communication product development services. IoT Solutions segment offers wireless temperature and other environmental condition monitoring services as well as employee task management services. The company generates majority of its revenue from the IoT Products & Services segment. Geographically, the company generates majority of its revenue from its business in the United States and also has its presence in Europe, Middle East and Africa and Rest of the world.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.